KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to -$105.2 million.

  • Emergent BioSolutions' Retained Earnings rose 4191.05% to -$105.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$105.2 million, marking a year-over-year increase of 4191.05%. This contributed to the annual value of -$212.4 million for FY2024, which is 87431.19% down from last year.
  • Per Emergent BioSolutions' latest filing, its Retained Earnings stood at -$105.2 million for Q3 2025, which was up 4191.05% from -$156.4 million recorded in Q2 2025.
  • Emergent BioSolutions' 5-year Retained Earnings high stood at $954.1 million for Q1 2022, and its period low was -$295.9 million during Q2 2024.
  • Over the past 5 years, Emergent BioSolutions' median Retained Earnings value was $289.7 million (recorded in 2023), while the average stood at $339.5 million.
  • Per our database at Business Quant, Emergent BioSolutions' Retained Earnings surged by 9462.5% in 2021 and then plummeted by 102812.5% in 2025.
  • Quarter analysis of 5 years shows Emergent BioSolutions' Retained Earnings stood at $950.3 million in 2021, then fell by 22.27% to $738.7 million in 2022, then crashed by 102.95% to -$21.8 million in 2023, then crashed by 874.31% to -$212.4 million in 2024, then soared by 50.47% to -$105.2 million in 2025.
  • Its last three reported values are -$105.2 million in Q3 2025, -$156.4 million for Q2 2025, and -$144.4 million during Q1 2025.